全球五味子市場:2020∼2027年

五味子(Schisandra Chinensis)，是深紅的果實，長時間用於中藥的植物。五味子在傳統中藥中被歸類為 "適應原" ，是指透過平衡身體功能來幫助人體維持體內穩態的植物或草藥。五味子漿果還具有強大的抗氧化保護作用，尤其是避免環境中的自由基與其他可能導致細胞損傷的毒素的侵害。 在中藥(TCM)中，五味子被認為具有抗衰老特性以及增強身體，心理和性耐受力的能力。 漿果種子可用於治療多種疾病，包括哮喘、咳嗽、消化不良、腹瀉、流感、失眠、皮膚過敏、心悸、胰島素抗性和經前綜合症。由於這些優勢，五味子市場，在預測期間內預計以7.56％的年複合成長率擴大。

本報告提供五味子市場相關調查，市場概要，以及各類型，各用途，各流通管道，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 全球五味子市場-範圍調查手法

• 調查手法
• 市場範圍

第2章 全球五味子市場-主要的趨勢與開發

第3章 全球五味子市場:摘要整理

• 各類型市場明細
• 各用途市場明細
• 各流通管道市場明細

第4章 全球五味子市場-市場動態

• 影響市場的要素
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析

第5章 全球五味子市場-產業分析

• 波特的五力分析
• 供應鏈分析
• 專利分析
• 法規分析

第6章 全球五味子市場，各類型

• 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%)，各類型
  • 各分類市場魅力指數，各類型
• 五味子*
  • 簡介
  • 市場規模分析，百萬美元，2018∼2027年及與前一年同期比較成長分析(%)，2019∼2027年
• 五味子

第7章 全球五味子市場，各用途

• 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%)，各用途
  • 各分類市場魅力指數，各用途
• 醫藥品*
  • 簡介
  • 市場規模分析，百萬美元，2018∼2027年及與前一年同期比較成長分析(%)，2019∼2027年
• 食品、飲料
• 化妝品

第8章 全球五味子市場，各流通管道

• 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%)，各流通管道
  • 各分類市場魅力指數，各流通管道
• 大賣場/超級市場*
  • 簡介
  • 市場規模分析，百萬美元，2018∼2027年及與前一年同期比較成長分析(%)，2019∼2027年
• 線上
• 直銷

第9章 全球五味子市場，各地區

• 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%)，各流通管道
  • 各分類市場魅力指數，各流通管道
• 北美
  • 簡介
  • 主要地區具體動態
  • 市場規模分析，及與前一年同期比較成長分析(%)，各類型
  • 市場規模分析，及與前一年同期比較成長分析(%)，各用途
  • 市場規模分析，及與前一年同期比較成長分析(%)，各流通管道
  • 市場規模分析，及與前一年同期比較成長分析(%)，各國
• 歐洲
  • 簡介
  • 主要地區具體動態
  • 市場規模分析，及與前一年同期比較成長分析(%)，各類型
  • 市場規模分析，及與前一年同期比較成長分析(%)，各用途
  • 市場規模分析，及與前一年同期比較成長分析(%)，各流通管道
  • 市場規模分析，及與前一年同期比較成長分析(%)，各國
• 南美
  • 簡介
  • 主要地區具體動態
  • 市場規模分析，及與前一年同期比較成長分析(%)，各類型
  • 市場規模分析，及與前一年同期比較成長分析(%)，各用途
  • 市場規模分析，及與前一年同期比較成長分析(%)，各流通管道
  • 市場規模分析，及與前一年同期比較成長分析(%)，各國
• 亞太地區
  • 簡介
  • 主要地區具體動態
  • 市場規模分析，及與前一年同期比較成長分析(%)，各類型
  • 市場規模分析，及與前一年同期比較成長分析(%)，各用途
  • 市場規模分析，及與前一年同期比較成長分析(%)，各流通管道
  • 市場規模分析，及與前一年同期比較成長分析(%)，各國
• 中東和非洲
  • 簡介
  • 主要地區具體動態
  • 市場規模分析，及與前一年同期比較成長分析(%)，各類型
  • 市場規模分析，及與前一年同期比較成長分析(%)，各用途
  • 市場規模分析，及與前一年同期比較成長分析(%)，各流通管道
  • 市場規模分析，及與前一年同期比較成長分析(%)，各國

第10章 全球五味子市場-競爭情形

• 競爭模式
• 其他競爭公司的策略分析
• 比較型組合分析
• 市場定位/佔有率分析
• 合併和收購分析

第11章 企業簡介

• Hunan Nuoz Biological Technology Co., Ltd
  • 企業概要
  • 類型組合和概要
  • 主要的焦點
  • 財務概要
• Shaanxi Fuheng (FH) Biotechnology Co., Ltd
• Suzhou Vitajoy Bio Tech. Ltd
• World-Way Biotech Inc
• Xi'an SR Bio-Engineering Co., Ltd.
• Herbo Nutra
• Greenutra Resource Inc.
• Nutra Green Biotechnology Co., Ltd.

第12章 全球五味子市場-重要考察

第13章 全球五味子市場-DataM

• 附錄
• 關於本公司、服務
• 諮詢方式

Market Overview:

Schisandra (Schisandra Chinensis) is a plant whose deep red berries have long been used in traditional Chinese medicine. Schisandra is classified as a "adaptogen" in traditional Chinese medicine, which refers to a plant or herb that helps the body maintain homeostasis by balancing its functions. Since it contains all five of the essential flavors of Chinese herbal medicine, the berry is sometimes referred to as the "five-flavor berry": sweet, salty, spicy, sour, and bitter. Since it has these flavors, it can benefit all five yin organs: the lungs, liver, heart, kidneys, and spleen. Schisandra berries also provide powerful antioxidant protection, particularly from free radicals and other toxins in the environment that may cause cellular damage. In Traditional Chinese Medicine (TCM), Schisandra is considered to have anti-aging properties as well as the ability to enhance physical, mental, and sexual endurance. The seeds of berries can be used to treat a number of illnesses, including asthma, cough, indigestion, diarrhea, flu, insomnia, skin allergies, heart palpitations, insulin resistance, and premenstrual syndrome. Due to its various advantages, the market for Schisandra is expected to grow with a CAGR of 7.56% during the forecast period. Schisandra market value is likely to reach USD XX thousand in 2028, from its recorded value of USD XX thousand in 2020.

Market Dynamics: Various health benefits of Schisandra is expected to drive the market growth

Schisandra is used to treat a variety of health problems. Schisandra can have a beneficial impact on a number of conditions and diseases, according to scientific evidence from animal and human studies. For instance, a 2017 study Trusted Source found that Schisandrin B had a beneficial, positive effect on Alzheimer's disease. Researchers discovered that positive effect was caused by Schisandrin B's ability to block formation of excess amyloid beta peptides in the brain. These peptides are one of the components that contribute to the formation of amyloid plaque, a material contained in Alzheimer's patients' brains. According to another study, Schisandrin B could be useful in the treatment of both Alzheimer's and Parkinson's disease. This is because it has an anti-inflammatory and neuroprotective effect on brain microglial cells. The effects of Schisandra extract on women suffering from menopausal symptoms were investigated in a 2016 study. For a year, 36 menopausal women were followed. Researchers discovered that Schisandra can help alleviate some of the symptoms of menopause. Schisandra also has adaptogenic properties which help the body resist the effects of anxiety and stress, plus bolster the body's defenses against stress. Additionally, schisandra offers great benefits for athletes.

Market Segmentation: Pharmaceuticals segment is expected to be the largest segment with a share of XX% during the forecast period.

The Schisandra market, on the basis of application, is segmented into the pharmaceuticals, food & beverages and cosmetics among others. The pharmaceuticals segment held the largest share as of 2020, owing to the widespread use of Schisandra extract in Traditional Chinese Medicine (TCM). Rising interest towards herbal dietary supplements and rapidly growing utilization of Schisandra extracts in these formulations will also propel the growth of the market. Schisandra is widely used for pharmaceutical applications across countries like China, Japan and South Korea. Schisandra is used by some people to help protect the liver from harm. It is also used for treating liver disease (hepatitis) and protecting the liver from poisons. Some people use Schisandra to assist with breathing issues such as wheezing, coughing, or shortness of breath. Others believe it would aid the body in stress adaptation and disease prevention. Schisandra is also used to slow down the aging process and increase lifespan, as well as to normalize blood sugar and blood pressure, stimulate the immune system, and speed up recovery after surgery. Deoxyschizandrin, a major dibenzocyclooctadiene lignan in Schisandra berries, has also been suggested to enhance lung cancer cells' responsiveness to anti-cancer drugs.

Geographical Penetration: Asia Pacific is expected to dominate the global Schisandra market

The Asia Pacific region accounted for the largest share of the regional Schisandra market. China dominated the Asia Pacific Schisandra market with a share of XX% in the year 2020. In China, it is popular to include medicinal plants of various kinds in foods to improve their overall health value. Schisandra is widely used in the food and beverage applications. According to the Chinese, drinking Schisandra berry tea for one hundred days will repair health completely. Drinking Schinsadnra berry tea every day, at least twice a day, can help lose at least two pounds a week. Infusing Schisandra berries with dark cherry juice is one way to achieve the weight-loss benefits of doing so on a daily basis. Cherry juice is also a blood and liver fortifier that has been related to weight loss through metabolism control. The anti-inflammatory properties of the Schisandra berries can be improved by the Vitamin C in dark cherry juice. Moreover, presence of key players in China is expected to drive the China Schisandra market from USD XX thousand in 2020, to USD XX thousand in 2028, growing with a CAGR of 8.41% during the forecast period. Hunan Nuoz Biological Technology Co., Ltd, Shaanxi Fuheng (FH) Biotechnology Co., Ltd, Suzhou Vitajoy Bio Tech. Ltd and Xi'an SR Bio-Engineering Co., Ltd. some of the key players in China Schisandra market.

Competitive Landscape:

The global Schisandra extract market is fragmented, with a large number of small players operating in the market. As the production of Schisandra is highly consolidated in few countries such as China, South Korea, Japan and Russia, extract producing companies are also bounded to these regions. Most of the major companies are operating in China with limited direct sales in global markets. The distribution of Schisandra extract in other countries is covered by local herbs, herbal extracts and phytochemical suppliers. Hunan Nuoz Biological Technology Co., Ltd, Suzhou Vitajoy Bio Tech. Ltd, Shanghai Freemen, Shaanxi Fuheng (FH) Biotechnology Co., Ltd and Greenutra Resource Inc. are some of the key players operating the market. Most of these companies are framing agreements with herbal medicine, supplements, food and cosmetic manufacturers for the supply of their Schisandra extract as an ingredient. Furthermore, these companies are focused towards the integration of value chain by entering in to supplement or other end-use formulation, thereby gaining a wide customer base and business margins

COVID-19 Impact: The market revenue for global Schisandra to shoot up to USD XX thousand in 2020 from nearly USD XX thousand in 2019, due to the pandemic

Herbal ingredients made from wild plants in Traditional Chinese Medicine (TCM) and other herbal-based products around the world is expected to rise dramatically as a result of the COVID-19 outbreak. Plants account for roughly 80% of TCM products in China. Wild plant species account for approximately 30% of TCM industrial production volume, accounting for 70% of the species. The TCM industry's resource base is made up of supply chains from China and around the world. COVID-19 patients in China are treated with a mixture of TCM and Western treatments, with official COVID-19 drug variants provided by the National Health Commission of the People's Republic of China. A study that screened 125 Chinese herbal medicines with the potential to directly inhibit COVID-19, as well as an analysis of historical records and human proof of SARS and H1N1 influenza prevention, are examples of research into the effectiveness of herbal treatments for COVID-19. Dried Schisandra berries, is one of the most frequently used plant species for SARS treatment.

Why Purchase the Report?

• Understand the current market scenario and viability of global Schisandra market over the forecast period.
• Visualize the composition of the global Schisandra market in terms of type, application and distribution channel to identify major players, growth potential, and market strategies
• Identify the key regulations prevailing in the market and understand their impact on the market over the forecast period
• Understand the key business factors such as market competition, product pricing, new product developments, and patent filings pertaining in the market

What we offer?

• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Excel data sheet with valuable data points of the global Schisandra market - Regional and Country level segmentation
• Product mapping in excel for the key products of all major market players
• Market Share Analysis covering business revenues ($) and revenue share (%) of key market players

Target Audience:

• Pharmaceuticals Manufacturers and Suppliers
• Farming Communities
• Cosmetic Companies
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals

Table of Contents

1. Global Schisandra Market -Scope and Methodology

• 1.1. Research Methodology
• 1.2. Scope of the Market

2. Global Schisandra Market -Key Trends and Developments

3. Global Schisandra Market - Executive Summary

• 3.1. Market Snippet by Type
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by Distribution Channel

4. Global Schisandra Market - Market Dynamics

• 4.1. Market impacting factors
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
• 4.2. Impact analysis

5. Global Schisandra Market - Industry Analysis

• 5.1. Porter's five forces analysis
• 5.2. Supply chain analysis
• 5.3. Patent Analysis
• 5.4. Regulatory Analysis

6. Global Schisandra Market - COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives

7. Global Schisandra Market - By Type

• 7.1. Introduction
  • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Type Segment
  • 7.1.2. Market attractiveness index, By Type Segment
• 7.2. Schisandra Chinensis*
  • 7.2.1. Introduction
  • 7.2.2. Market size analysis, US$ million, 2019-2028 and y-o-y growth analysis (%), 2020-2028
• 7.3. Schisandra Sphenanthera

8. Global Schisandra Market - By Application

• 8.1. Introduction
  • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
  • 8.1.2. Market attractiveness index, By Application Segment
• 8.2. Pharmaceuticals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 And Y-O-Y Growth Analysis (%), 2020-2028
• 8.3. Food & Beverages
• 8.4. Cosmetics

9. Global Schisandra Market - By Distribution Channel

• 9.1. Introduction
  • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By Distribution Channel Segment
  • 9.1.2. Market attractiveness index, By Distribution Channel Segment
• 9.2. Hypermarkets/Supermarkets*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 And Y-O-Y Growth Analysis (%), 2020-2028
• 9.3. Online
• 9.4. Direct Sales

10. Global Schisandra Market - By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key region-specific dynamics
  • 10.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
  • 10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
  • 10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
  • 10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
  • 10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel

11. Global Schisandra Market - Competitive Landscape

• 11.1. Competitive scenario
• 11.2. Competitor strategy analysis
• 11.3. Comparative type portfolio analysis
• 11.4. Market positioning/share analysis
• 11.5. Mergers and acquisitions analysis

12. Company Profiles

• 12.1. Hunan Nuoz Biological Technology Co., Ltd*
  • 12.1.1. Company Overview
  • 12.1.2. Type Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Shaanxi Fuheng (FH) Biotechnology Co., Ltd
• 12.3. Suzhou Vitajoy Bio Tech. Ltd
• 12.4. World-Way Biotech Inc
• 12.5. Xi'an SR Bio-Engineering Co., Ltd.
• 12.6. Herbo Nutra
• 12.7. Greenutra Resource Inc.
• 12.8. Nutra Green Biotechnology Co., Ltd.

13. Global Schisandra Market - Premium Insights

14. Global Schisandra Market - DataM

• 14.1. Appendix
• 14.2. About us and services
• 14.3. Contact us